Thatcher Plans to Do More With Less

LONDON—Prime Minister Thatcher's landslide victory in Britain's general election June 11 means that U.K. science is unlikely to receive more money from her Conservative government. Instead, the scientific community is bracing for changes designed to make better use of existing funds. The state of British science rarely surfaced in a campaign pre occupied with welfare and defense. Although both main opposition parties—Labour and the alliance of the Liberals and Social Demo crats̵

Written byJon Turney
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The state of British science rarely surfaced in a campaign pre occupied with welfare and defense. Although both main opposition parties—Labour and the alliance of the Liberals and Social Demo crats—made promises to increase R&D spending, their poor showing puts little pressure on the Thatcher government to heed their advice.

The ruling Conservatives responded to warnings that basic re search in the United Kingdom is in decline with a statement that "a country our size cannot afford to do everything." The only public meeting of the campaign on science, arranged by the lobby group Save British Science, drew 100 people.

At the same time, there are plans to reform British science policy. The government has announced it will reduce the share of the R&D budget going to defense (see The Scientist, June 1, p. 1). And the third-term administration is expected to move swiftly to set up a new Advisory ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies